ZA201606704B - Topical corticosteroid compositions - Google Patents

Topical corticosteroid compositions

Info

Publication number
ZA201606704B
ZA201606704B ZA2016/06704A ZA201606704A ZA201606704B ZA 201606704 B ZA201606704 B ZA 201606704B ZA 2016/06704 A ZA2016/06704 A ZA 2016/06704A ZA 201606704 A ZA201606704 A ZA 201606704A ZA 201606704 B ZA201606704 B ZA 201606704B
Authority
ZA
South Africa
Prior art keywords
topical corticosteroid
corticosteroid compositions
compositions
topical
corticosteroid
Prior art date
Application number
ZA2016/06704A
Other languages
English (en)
Inventor
Priyadarshani Sahukar
Franklin Okumu
Sateesh Kandavilli
Original Assignee
Promius Pharma Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Promius Pharma Llc filed Critical Promius Pharma Llc
Publication of ZA201606704B publication Critical patent/ZA201606704B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA2016/06704A 2014-03-11 2016-09-28 Topical corticosteroid compositions ZA201606704B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201461951165P 2014-03-11 2014-03-11
PCT/US2015/020031 WO2015138650A1 (en) 2014-03-11 2015-03-11 Topical corticosteroid compositions
US14/645,338 US20150258119A1 (en) 2014-03-11 2015-03-11 Topical corticosteroid compositions
PCT/US2015/049244 WO2016144381A1 (en) 2014-03-11 2015-09-09 Topical corticosteroid compositions

Publications (1)

Publication Number Publication Date
ZA201606704B true ZA201606704B (en) 2019-07-31

Family

ID=52727460

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2016/06704A ZA201606704B (en) 2014-03-11 2016-09-28 Topical corticosteroid compositions

Country Status (13)

Country Link
US (4) US20150258119A1 (enExample)
EP (2) EP3116473B1 (enExample)
JP (2) JP6487949B2 (enExample)
KR (2) KR101930244B1 (enExample)
CN (1) CN106659682B (enExample)
AU (2) AU2015229403B2 (enExample)
BR (1) BR112016021023A2 (enExample)
CA (2) CA2945943C (enExample)
EA (2) EA201691808A8 (enExample)
ES (1) ES2857602T3 (enExample)
MX (2) MX381164B (enExample)
WO (2) WO2015138650A1 (enExample)
ZA (1) ZA201606704B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9364485B2 (en) 2009-08-31 2016-06-14 Dr. Reddy's Laboratories Ltd. Topical formulations comprising a steroid
US20160184431A1 (en) 2014-03-11 2016-06-30 Promius Pharma Llc Topical compositions comprising a corticosteroid
WO2017091168A1 (en) * 2015-11-28 2017-06-01 Pharmacti̇ve İlaç San. Ve Ti̇c. A.Ş. A topical spray comprising isoconazole nitrate and difluocortolone valerate
CA3011015C (en) 2016-01-12 2024-04-16 Nortic Holdings Inc. Betamethasone oral spray formulation and method of use to treat ataxia
GB201604316D0 (en) 2016-03-14 2016-04-27 Avexxin As Combination therapy
US20180028766A1 (en) * 2016-07-27 2018-02-01 Sun Pharmaceutical Industries Limited Touch-free topical spray of halobetasol
CA3037582A1 (en) 2016-09-21 2018-03-29 Avexxin As Pharmaceutical composition
US10543177B2 (en) 2017-04-11 2020-01-28 Kevin Mrohs Composition and method for treating skin conditions
US11620886B2 (en) 2018-02-19 2023-04-04 Invue Security Products Inc. Merchandise security system with inductive charging
WO2020069448A1 (en) * 2018-09-28 2020-04-02 Joel Studin Transpore delivery of steroids and large molecules
JP7412292B2 (ja) * 2019-07-10 2024-01-12 積水化学工業株式会社 製剤
WO2021080527A1 (en) * 2019-10-24 2021-04-29 Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A.Ş. Topical pharmaceutical compositions containing difluocortolone and isoconazole
EP4103151A1 (en) * 2020-02-11 2022-12-21 Taro Pharmaceutical Industries Ltd. Compositions comprising desoximetasone and tazarotene
US11382863B2 (en) * 2020-03-04 2022-07-12 Somerset Therapeutics Llc Injectable suspension comprising an insoluble corticosteroid and a soluble corticosteroid
CN113092601B (zh) * 2021-03-02 2022-12-20 苏州市药品检验检测研究中心 一种化妆品中倍他米松17-丙酸酯及倍他米松21-丙酸酯的检测方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3892856A (en) 1974-04-10 1975-07-01 Squibb & Sons Inc Topical steroid formulation
US3934013A (en) 1975-02-21 1976-01-20 Syntex (U.S.A.) Inc. Pharmaceutical composition
US4343798A (en) 1981-06-23 1982-08-10 The Procter & Gamble Company Topical antimicrobial anti-inflammatory compositions
US4552872A (en) * 1983-06-21 1985-11-12 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing corticosteroids
US5422361A (en) * 1989-12-20 1995-06-06 Schering Corporation Stable cream and lotion bases for lipophilic drug compositions
IT1247529B (it) 1991-04-24 1994-12-17 Poli Ind Chimica Spa Composizioni farmaceutiche in forma di schiuma per somministrazione intravaginale, cutanea e orale
DE19536246A1 (de) 1994-09-30 1996-04-04 Juergen Dr Regenold Pharmazeutische Zusammensetzung
GB9504265D0 (en) 1995-03-03 1995-04-19 Medeva Plc Corticosteroid-containing pharmaceutical composition
IL152486A0 (en) * 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US7820145B2 (en) * 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20080206161A1 (en) * 2002-10-25 2008-08-28 Dov Tamarkin Quiescent foamable compositions, steroids, kits and uses thereof
CL2004001884A1 (es) * 2003-08-04 2005-06-03 Pfizer Prod Inc Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros.
ZA200507018B (en) * 2003-12-16 2008-02-27 Foamix Ltd Oleaginous pharmaceutical and cosmetic foam
CN101048136B (zh) * 2004-08-31 2011-06-22 施蒂福研究澳大利亚股份有限公司 微乳化和亚微米乳化方法和组合物
TWI397427B (zh) * 2004-08-31 2013-06-01 史迪費爾研究澳洲股份有限公司 微乳化液、次微米乳化液的方法及組成物
US20060246098A1 (en) * 2005-03-16 2006-11-02 Srinivasa Rao Stable aqueous-based emulsion formulation comprising urea and salicylic acid and method of using same
DK1885373T3 (en) 2005-04-25 2015-08-10 Dow Pharmaceutical Sciences Use of a spray formulation of clobetasol for the treatment of psoriasis
GB2443162B (en) 2006-10-28 2011-02-09 Nupharm Lab Ltd Betamethasone spray
US9364485B2 (en) 2009-08-31 2016-06-14 Dr. Reddy's Laboratories Ltd. Topical formulations comprising a steroid
AU2010302350B2 (en) * 2009-10-02 2015-06-18 Journey Medical Corporation Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
NL2004437C2 (en) * 2010-03-19 2011-09-20 Forte Iq B V Spray-pumpable comprising composition suitable for topical skin application.
ES2918299T3 (es) * 2010-06-11 2022-07-15 Prec Dermatology Inc Composiciones de espuma a base de aerosol emoliente con alto contenido de aceite
RU2015108059A (ru) * 2012-08-10 2016-09-27 Асахи Гласс Компани, Лимитед Способ получения карбонатного соединения и способ получения ароматического поликарбоната
CA2905587A1 (en) * 2013-03-15 2014-09-18 Medicis Pharmaceutical Corporation Topical compositions of flunisolide and methods of treatment
HK1223300A1 (zh) * 2013-06-03 2017-07-28 Tolmar, Inc. 皮质类固醇组合物

Also Published As

Publication number Publication date
CA2946201C (en) 2020-10-27
JP6487949B2 (ja) 2019-03-20
CA2945943A1 (en) 2015-09-17
AU2015229403A1 (en) 2016-10-27
MX381164B (es) 2025-03-12
BR112016021023A8 (pt) 2018-01-30
CN106659682A (zh) 2017-05-10
AU2015229403B2 (en) 2019-05-02
MX2016011842A (es) 2017-02-02
EP3197432A1 (en) 2017-08-02
EA201691808A1 (ru) 2017-02-28
JP2017508802A (ja) 2017-03-30
CN106659682B (zh) 2020-12-29
CA2946201A1 (en) 2016-09-15
EA201692334A1 (ru) 2018-02-28
ES2857602T3 (es) 2021-09-29
JP6535735B2 (ja) 2019-06-26
US20200230155A1 (en) 2020-07-23
KR20160144377A (ko) 2016-12-16
AU2015385750A1 (en) 2016-10-27
WO2016144381A1 (en) 2016-09-15
US20160030450A1 (en) 2016-02-04
AU2015385750B2 (en) 2019-01-31
KR101930246B1 (ko) 2018-12-18
BR112016021023A2 (pt) 2021-09-14
CA2945943C (en) 2020-10-27
EA201691808A8 (ru) 2017-04-28
US20180250312A1 (en) 2018-09-06
EP3116473B1 (en) 2020-12-30
WO2015138650A1 (en) 2015-09-17
EP3197432A4 (en) 2018-10-10
EP3116473A1 (en) 2017-01-18
KR20170023791A (ko) 2017-03-06
MX2016011841A (es) 2017-02-02
US20150258119A1 (en) 2015-09-17
JP2017530974A (ja) 2017-10-19
KR101930244B1 (ko) 2018-12-18

Similar Documents

Publication Publication Date Title
ZA202007965B (en) Topical pharmaceutical compositions
ZA201800080B (en) Topical retinoid compositions
SG11201701292XA (en) Topical formulation
SG11201705415YA (en) Multi-supplement compositions
IL257131A (en) Preparations
GB201515387D0 (en) Compositions
EP3197432A4 (en) Topical corticosteroid compositions
GB201501598D0 (en) Compositions
IL256559B1 (en) Flinbolin preparations
GB201515391D0 (en) Compositions
GB201709111D0 (en) Antibiofilm compositions
GB201622118D0 (en) Set on demand compositions
EP3221420A4 (en) Photochromic-electrochromic compositions
SG11201706938XA (en) Topical formulation
SI3349766T1 (sl) Antihemoragični sestavki
GB201504307D0 (en) Composition
GB201408167D0 (en) Compositions
IL251479A0 (en) components
GB2538335B (en) Compositions
GB201400647D0 (en) Topical composition
GB201420306D0 (en) Compositions
PL3393503T3 (pl) Kompozycje
EP3322482C0 (en) TOPICAL CIPROFLOXACIN COMPOSITIONS
GB201513108D0 (en) Topical composition
GB201400348D0 (en) Topical composition